$LEG

LEGGETT & PLATT INC

No enriched coverage for $LEG in the last 7 days.

No SEC Form 4 filings for $LEG in the last 30 days.

Med

Leggett & Platt stock (US5246601075): dividend under pressure after payout suspension and credit downgrade

Leggett & Platt has suspended its dividend and faced a credit rating downgrade to BB+ with a negative outlook, due to restructuring efforts and balance sheet concerns. The company, a major supplier in the US furnishings supply chain, is undergoing a strategic review to simplify its portfolio and reduce leverage. This shift impacts its investment profile, moving focus from dividend income to long-term balance sheet health and restructuring execution.

Leggett & Platt (LEG) CFO receives stock grant and updates holdings

Leggett & Platt's Executive Vice President and CFO, Benjamin Michael Burns, received a stock award of 136.5034 shares of common stock valued at $8.2365 per share. This grant increased his direct holdings to 190,673.0931 shares and the filing also detailed his indirect holdings, including shares in retirement plans and those held by his spouse. The transactions were reported in an SEC Form 4 filing, indicating a compensation-related grant.

Is Leggett & Platt, Incorporated (LEG) A Good Stock To Buy Now?

Shares of Leggett & Platt, Incorporated (LEG) are trading at a low valuation due to challenging market conditions in key end markets. The company, a diversified manufacturer, has attracted an unsolicited bid from Somnigroup (SGI) at $12 per share, with potential for a higher negotiated offer. This acquisition would offer significant vertical integration benefits and strategic advantages within the bedding industry, presenting a compelling risk/reward scenario for investors.